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Abstract: Coeliacdiseaseischaracterisedbyinflammationofsmallintestinalmucosaaccompaniedbyabnormalvillousarchitecture.Itisnow
acceptedthatsomepatientswithpositivecoeliacserologytestsmayhaveminormucosallesionsthatmaynotbeapparentonroutine
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Coeliac disease is a gluten sensitive enteropathy 
characterised by inflammation of the small intestinal 
mucosa, with a range of abnormal villous architecture 
and crypt hyperplasia features [1-3]. However, several 
studies have reported only minimal intestinal changes 
in some patients with positive coeliac serology [4-6]. 
In a proportion of these patients, detailed histological 
analysis reveals subtle histological abnormalities such 
as nuclear disarray, irregular cell shape [7], and an 
increased number of intraepithelial lymphocytes [4-6] 
with this increase sometimes confined to the villous 
tip [8,9]. In this clinical setting, the diagnosis of coeliac 
disease may be missed, unless the patient is regularly 
monitored for more definitive evidence of gluten sensitive 
enteropathy. 
Cytoskeletal proteins are involved in essentially 
all structural and dynamic aspects of the living cell, 
including maintenance of cell shape, movement, 
replication, apoptosis, differentiation and intracellular 
signalling [10-12].  Disruption of cytoskeletal structures 
can severely limit cell function, and if not reversed 
can adversely affect cell integrity and viability [13-15]. 
Rearrangement of the cytoskeletal proteins is thought 
to result in nuclear disarray and alteration of enterocyte 
Cent. Eur. J. Biol. • 3(3) • 2008 • 258–267
DOI: 10.2478/s11535-008-0029-2
258
B.M. Mohamed et al.
shape, described features of the coeliac lesion [7]. 
Many other pathological conditions also demonstrate 
abnormalities in cytoskeletal proteins, including several 
cardiovascular disease syndromes, neurodegeneration, 
cancer, liver cirrhosis, pulmonary fibrosis, and skin 
diseases [16-20].
The cytoskeleton of eukaryotic cells is composed 
of three major protein families that form filamentous 
structures running throughout the cell: microfilaments 
consisting of different actin isoforms, microtubules 
made of α- and β-tubulin, and the intermediate filaments 
[10,11,21]. The actin network has been shown to play 
an important role in gliadin-induced effects on intestinal 
epithelial cells, demonstrated by both in vivo and in vitro 
studies [22,23]. Moreover, when coeliac patients on a 
gluten-free diet were exposed to gliadin, this resulted 
in disarrangement of intestinal mucosal actin filaments 
in vivo [24-26]. It has also been demonstrated that Zo-1 
expression is reduced in the intestinal mucosa of patients 
with active coeliac disease and this is associated with 
a disrupted F-actin organization; these changes were 
reversed by gluten free diet treatment [27].  
In this study, a new technology called high content 
analysis was used to study details of enterocyte 
morphology and their tubulin cytoskeletal structures in 
biopsy tissue from patients with coeliac disease. This 
system is based on automated extraction of data from 
cellular images and is proving to be an invaluable 
tool for the investigation of cytoskeletal networks, 
allowing study of their complex dynamic changes at 
a qualitatively new level of detail [28].  Employing the 
morphology explorer bioapplication tool Cellomics®, the 
system has been used to quantify fluorescent images 
of the cytoskeleton in the NIH 3T3 cell line [28]. In this 
study, biopsy tissue from patients with coeliac disease, 
patients with potential coeliac disease and from disease 
control subjects was examined.  It was hypothesized that 
changes in cell morphology and cytoskeletal structures 
might be present in enterocytes from patients with 
potential coeliac disease, even before the development 




Duodenal biopsies from two patient groups were 
examined.  These included untreated and treated coeliac 
disease patients.  The duodenal histology in 14 patients 
with untreated disease, all with positive endomysial 
antibody tests, demonstrated partial villous atrophy and 
crypt hyperplasia.  Ten further coeliac patients, treated 
with a gluten free diet, were endomysial antibody 
negative.  Demographic and serological details of these 
two patient groups are given in Table 1.
2.1.2. Non-coeliac subjects
The non-coeliac control group comprised 20 subjects 
who had been investigated because of symptoms 
of dyspepsia but had normal duodenal mucosa and 
negative endomysial antibodies (Table 1).
2.1.3. Study group subjects 
This group comprised six patients with positive 
endomysial antibody tests who had an apparently normal 
duodenal mucosa (Figure 1A); these patients presented 
with symptoms consistent with malabsorption and are 
Patients (n) Sex Age, years 
(range)
EMA status
Males Females Positive Negative
UTCD                         (14) 4 10 52 (35-74) 14 0
TCD                            (10) 4 6 54 (31-57) 0 10
Non-coeliac controls    (20) 9 11 55 (33-82) 0 20
Table 1. Demographic and serologic details of the coeliac groups and non-coeliac controls.
UTCD: untreated coeliac disease; TCD: treated coeliac disease; EMA: endomysial antibody
Figure 1. H&E stained sections demonstrating the routine histo-
logical image of the study group subjects with normal 
duodenal mucosa (A) and after the intestinal lesion was 
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Pt.no Age (years) Sex Symptoms EMA Hb Ferritin
1 20 F Anaemia + 4.9
2 49 F Bloating, dyspepsia, weight loss + 13 3.9
3 67 F Bloating, diarrhoea, dyspepsia + 8.7
4 54 M Fatigue +
5 34 F Anaemia, diarrhoea, fatigue + 11 3.9
6 67 F Weight loss + 12
referred to throughout the manuscript as the study group 
subjects.  Demographic, clinical and laboratory features 
of these patients are presented in Table 2. Based on 
their normal laboratory findings, none of these patients 
were considered to have coeliac disease and they 
were discharged to their primary care physicians. As 
part of the study, follow up serological and histological 
evaluation was performed after a mean of 7.5 years 
(range 5-11 years).  This revealed that these patients 
continued to have positive coeliac serology and all had 
developed a small intestinal lesion (ranging from partial 
to total villous atrophy) suggestive of coeliac disease 
(Figure 1B).  The intestinal lesion was scored according 
to a modified Marsh scale [29]. The original biopsies 
in the six subjects were subsequently re-evaluated by 
two blinded histopathologists and again considered to 
be normal, except in the case of one patient in whom 
the intra-epithelial lymphocyte count was increased. 
Additional details concerning these patients have been 
previously reported [30].
2.2. Ethics approval
Ethical approval for this study was granted by the 
Joint Ethics Committee of St James’s Hospital, Dublin, 
Ireland.
2.3. Immunofluorescent technique
2 µm-thick duodenal sections from paraffin-embedded 
blocks were placed on uncoated glass slides and 
dried overnight at 52°C. Sections were dewaxed and 
rehydrated in a series of graded xylene and alcohol 
solutions and subsequently immersed in phosphate-
buffered saline solution (PBS) at pH 7.4.  Sections were 
then preheated for antigen retrieval in a microwave oven 
in 0.1 M citrate buffer pH 6.0 for 20 minutes on high 
power and cooled for 20 minutes at room temperature. 
After immersing the prepared samples in PBS, the 
sections were next incubated with anti-α-tubulin 
antibody (clone B-5-1-2, Sigma, St Louis, MO) at 1:100 
dilution in antibody buffer (0.05% bovine serum albumin 
and 0.1 sodium azide in PBS) for 60 minutes at 4ºC. 
Sections were then incubated with Alexa® (Molecular 
Probes, Eugene, OR) fluorescent conjugated secondary 
antibody at 1:500 in dilution buffer for 30 minutes.  Cell 
nuclei were counterstained with 1µM Hoeschst 33258 
(Sigma, St Louis, MO). After each antibody application, 
sections were washed twice in PBS.  Sections were 
then mounted with DAKO fluorescent mounting media 
(Sigma, St Louis, MO) and kept in the dark at 4ºC until 
analysis.  Negative control samples were incubated with 
isotype-matched control immunoglobulins instead of 
monoclonal antibodies.
2.4. Quantification and image acquisition 
Once sections were stained and dried, slides were 
attached onto the custom-modified slide holder 
developed for imaging on the Cellomics® Kineticscan 
reader.  Three-colour image sets were acquired at 40x 
dry lens magnification.  Quantitative data from stored 
digital images of the enterocytes were processed using 
the morphology explorer bioapplication tool Cellomics®. 
This bioapplication was optimized for cell morphology 
analysis, including cytoskeletal rearrangements and 
Hoechst-stained nuclei.  “Virtual” scans were carried out 
using specific assay parameters of fluorescent images of 
the enterocytes in each histological section. These were 
acquired and analyzed by proprietary image processing 
algorithms.
2.5. Optimization of image acquisition
The morphology explorer bioapplication was originally 
designed as a general tool that can perform a wide 
range of measurements related to cell morphology. The 
features and capabilities provide researchers with the 
flexibility to design their own assays.  However, to date, 
this bioapplication has only been used to analyse cell 
lines. In this study, a new application was developed 
to allow examination of paraffin-embedded duodenal 
sections, so that individual cells within selected tissue 
areas could be analyzed in situ. A methodology was 
devised so that a 96 well plate could be used as a slide 
holder, with a system for identifying the duodenal tissue 
Table 2. Age, sex, clinical symptoms and laboratory results in the study group subjects.
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Figure 2. Algorithmic created images representing enterocyte length and width in small intestinal mucosa in the normal control group (non-
coeliac) (A), Untreated coeliac disease (B) and in the study group subjects (first biopsy) (C). Red arrow represents the enterocyte length 
and yellow arrow represents their width.  (magnification x40).  The enterocyte length and width was measured based on the tubulin fibre 
staining using the optimized bioapplication tools. 
region of interest (middle third of the villi) using a field map. 
To examine enterocytes individually (Figure 2), 
we used three different fluorescent channels, each 
determining a specific morphological feature of the 
enterocyte. Furthermore, we set up parameters to 
examine whole cells and cytoskeletal fibre arrangement. 
These parameters (background correction, smooth 
factor in channel 1 and 2, object segmentation in 
channel 1 and 2, fibre detection and fibre alignment 
in channel 3) were activated simultaneously. Thus, we 
were able to measure the cell length, width, nuclear 
shape and the tubulin fibre profiles in each individual 
enterocyte from the duodenal sections. In some 
instances, enterocytes appeared to overlay each other; 
however, using the morphology explorer bioapplication 
tools it was possible to ensure that the measurement of 
only single cells was calculated.   
2.6. Statistical analysis
The 95% confidence intervals (CI) of the enterocyte’s 
structure characterization and the tubulin fibre profiles 
for all four patient groups were calculated. The Mann-
Whitney U test was then used to assess the statistical 
significance of differences. A P-value of <0.05 was 
considered to be statistically significant.
3. Results 
                                                 
The approximate measurements of the enterocyte 
shape were calculated based on the output features 
from the algorithmic image of the gross pattern of 
tubulin staining [28]. In each biopsy, a minimum of ten 
enterocytes were examined. The mean and 95% CI of 
enterocyte measurements and the tubulin fibre profiles 
Table 3. Characteristics of enterocyte morphology and tubulin profiles in the patient groups.
UTCD: untreated coeliac disease patients; TCD: treated coeliac disease patients; SGS: study group subjects. Results are expressed as 
mean and 95% confidence intervals.
Measurements Normal control 
(non-coeliac) group




Enterocyte length 67 pixels (65- 74) 53 pixels (47-59) 56 pixels (65-74) 57 pixels (47- 67) 57 pixels (49- 65)
Enterocyte width 11 pixels (10-12) 13 pixels (11 -14) 12 pixels (11-13) 11 pixels (9-12) 14 pixels (13-16)
Enterocyte tubulin 
fibre angles degree




174 pixels (124-220) 330 pixels (249-411) 230 pixels (150-310) 290 pixels (161-419) 373 pixels (201-545)
Enterocyte tubulin 
fibre density
48 pixels (43-54) 64 pixels (59-69) 59 pixels (49-68) 65 pixels (52-77) 66 pixels (54-78)
Enterocyte nuclear 
shape (roundness)
1.59 pixels (1.54-1.64) 1.28 pixels (1.25-1.31) 1.50 pixels (1.45-1.55) 1.38 pixels (1.27-1.48) 1.25 pixels (1.15-1.35)
Enterocyte nuclear 
length width ratio
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Figure 3. Quantification data of enterocyte morphology and tubulin structures in the normal control (non-coeliac) group, untreated coeliac disease 
patients (UTCD), treated coeliac disease patients (TCD) and in the study group subjects (SGS) (first and second duodenal biopsies). 
(magnification x40).  Differences between the groups were calculated using the Mann-Whitney U test. 
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are summarized in Table 3. Results are expressed 
as the mean and range in pixels. Likewise, details of 
nuclear data are summarized in Table 3.  
3.1. Enterocyte length
The enterocyte length was measured along the medial 
axis of the cells. In biopsy tissue from normal (non-
coeliac) subjects, the mean enterocyte length was 67 
pixels (range 65-74; Figure 2A). The enterocyte length 
was significantly reduced in all the patient groups 
(Figure 3A): in the untreated coeliac patients (mean 53 
pixels, p<0.000; Figure 2B), in treated coeliac patients 
(mean 56 pixels, p<0.001) in the first biopsy of the study 
group subjects (mean 57 pixels p<0.01; Figure 2C) 
and in the second biopsy in the study group subjects 
(mean 57 pixels, p<0.006). Of note, the results were not 
statistically different within the all patient groups.    
3.2. Enterocyte width 
Enterocyte width was measured perpendicular to the 
middle axis of the cell. In the normal (non-coeliac) 
subjects, the mean enterocyte width was 11 pixels 
(range 9-12; Figure 2A). This was significantly lower 
than that found in the untreated coeliac patients (mean 
14 pixels, p<0.002; Figure 2B) and the second biopsy 
in the study group subjects (mean 13 pixels, p<0.03; 
Figure 2C). Interestingly, the enterocyte width in the 
treated coeliac patients and in the initial biopsy of the 
study group subjects was similar to the non-coeliac 
control subjects (Figure 3B).   
3.3. Enterocyte tubulin fibre angles
Fibre angle measurement represents the degree of 
intracellular branching of tubulin. These measurements 
were performed based on the algorithmic referenced 
angles.  Normal cells containing radially oriented fibres, 
such as tubulin fibres radiating from the cell center, have 
large degree angles. This is what was found in the normal 
(non-coeliac) columnar epithelial cells, which displayed 
a high tubulin angle degree (mean 8.6: range 7.8-9.4). 
Enterocyte tubulin fibre angles were significantly reduced 
in all the patient groups, except in the treated coeliac 
patients (Figure 3C); in the untreated coeliac patients, 
the mean angle degree was 7.2 (p<0.010); in first biopsy 
of the study group subjects, mean 6.6 (p<0.01); in the 
second biopsy of the study group subjects, mean 6.4 
(p<0.005). Furthermore, the treated coeliac patients 
showed a significantly higher angle degree, mean 8.3, 
than the untreated coeliac patients (p<0.04) and the 
second biopsies in the study group subjects (p<0.02). 
3.4. Enterocyte tubulin fibre staining intensity 
In the tissue from normal (non-coeliac) subjects, the 
mean intensity of enterocyte tubulin fibre staining was 
174 pixels (range124-220). Staining intensity was 
significantly greater in all the patient groups except in 
the treated coeliac patients (Figure 3D): in the untreated 
coeliac patients, the mean intensity was 330 pixels 
(p<0.001); in the first biopsy in the study group, the 
mean intensity was 290 pixels (p<0.04); in the second 
biopsy in the study group, the mean intensity was 373 
pixels (p<0.006). Within these three patient groups, no 
significant difference in the level of staining intensity 
was found (Table 3). The treated coeliac group, on the 
other hand, did not show any difference in comparison 
to the normal (non-coeliac) control group. 
3.5. Enterocyte tubulin fibre density 
The surface area density is a texture measurement 
which takes into account both the intensity variation and 
spatial distribution of the pixels within the enterocytes. 
In enterocytes from normal (non-coeliac) subjects, the 
mean tubulin fibre density was 48 pixels (range 43-
54). Enterocyte tubulin fibre density was significantly 
increased in all the patient groups, with the exception 
of treated coeliac patients (Table 3): in the untreated 
coeliac patients, the mean density value was 64 pixels 
(p<0.001); in the first biopsy of the study group, the 
mean density was 65 pixels (p<0.01); and in the second 
biopsy of the study group subjects, the mean density 
was 66 pixels (p<0.01; Figure 3E). 
3.6. Nuclear shape (roundness) 
In the normal enterocyte, the nucleus has an elliptical 
shape. The measurement of the nuclear shape is based 
on the perimeter square area of the nucleus (P2A). 
A higher nuclear P2A value is found in the nucleus of 
normal columnar epithelial cells, reflecting their elliptical 
shape. As the nuclear shape develops a more rounded 
shape, the closer the P2A unit gets to a value of 1. This 
feature was investigated in this study in the normal (non-
coeliac) subjects and the patient groups (Figure 3F).  In 
the biopsies from non-coeliac subjects, the mean P2A 
value was 1.59 pixels (range 1.54-1.64; Figure 4A). 
The P2A values were significantly closer to one in all 
the patient groups, in comparison to the non-coeliac 
subjects (Figure 4A); in the untreated patients, mean 
1.28 pixels (p<0.0001; Figure 4B); in the treated coeliac 
patients mean 1.50 pixels (p<0.0001); in the first biopsy 
of the study group subjects mean 1.38 pixels (p<0.001; 
Figure 4C); and in the second biopsy of the study group 
subjects mean 1.25 pixels (p<0.0003). Of interest, the 
nuclear P2A values in the treated coeliac patients were 
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significantly greater than the untreated coeliac patients 
(p<0.001), than the first biopsy of the study group 
subjects (p<0.01) and than the second biopsy in the 
study group subjects (p<0.0002).
3.7. Nuclear length and width ratio (LWR) 
The enterocyte nuclear length and width ratio (LWR) 
was also examined based on the P2A. A high nuclear 
LWR value is found in the nucleus of normal columnar 
epithelial cells and in the biopsy tissue from the normal 
(non-coeliac) subjects (Figure 3G), the mean nuclear 
LWR was 2.01 pixels (range 1.92-2.20). In comparison 
with the non-coeliac subjects, the nuclear LWR was 
significantly reduced in the untreated coeliac patients, 
mean 1.47 pixels (p<0.0001); in the first biopsy of the 
study group, mean 1.78 pixels (p<0.01); and in the 
second biopsy in the study group, mean 1.54 pixels 
(p<0.0005). In the treated coeliac patients, nuclear 
LWR was not significantly different from the non-coeliac 
subjects.   
4. Discussion
This is the first study to examine enterocyte morphology 
in histological tissue sections using digitalized high 
content analysis. This technology, in combination with 
a bioapplication software package named morphology 
explorer, was used to accurately quantify enterocyte 
length and width, nuclear shape and both tubulin 
fibre alignment and texture. Duodenal biopsy tissue 
from patients with coeliac disease and from non-
coeliac control subjects was examined. In addition, 
histological sections from a group of patients with a 
positive endomysial antibody test - before and after the 
development of an observable duodenal histological 
lesions (designated the “study group subjects”) - were 
investigated. When these study group subjects were 
originally investigated, no histological lesion was noted, 
although this might have been due to the presence of 
patchy disease [4-6] or when subtle abnormalities, only 
detectable by immunohistochemistry, were present [30]. 
Significant differences in enterocyte morphology and 
intracellular structures were demonstrated in all the 
patient groups in comparison to the control subjects.
High content analysis was originally designed 
to study cells in suspension [31-33] and there are 
no previous reports of employing this technology to 
examine cells in fixed tissue sections.  In this study, we 
were able to modify the technology and demonstrate a 
new application for this system: This allowed detailed 
analysis of cell morphology and intracellular cytoskeletal 
structures of individual cells in tissue sections. This is 
a considerable advance on computer aided image 
analysis which, although helpful in tissue analysis, does 
not allow for similar detailed examination of individual 
cells [34,35]. 
A decrease in epithelial cell height and increase in cell 
width are commonly described features of enterocytes 
in coeliac disease [7]. Using high content analysis, a 
statistically significant reduction in enterocyte length 
(or height) was found in both untreated and treated 
coeliac patient groups. Of interest, a similar reduction 
in length was also evident in the study group subjects in 
both sets of samples i.e. before an apparent histological 
lesion and after the development of a lesion. In the case 
of enterocyte width, a significant increase in width was 
only present in the untreated coeliac patients and in the 
second set of biopsies from the study group.  
The shape of cell nuclei was a further morphological 
feature, which was investigated in these biopsies. Earlier 
studies employing high content analysis have reported 
that the cell nucleus is a valid object for morphological 
quantification [31-33]. In contrast to the elliptical 
shape found in normal enterocytes, in coeliac disease 
cell nuclei tend to have a more rounded appearance 
[7]. Using the analytical system described here, this 
observation was confirmed and it was demonstrated 
that a significant shape alteration was found not only in 
the coeliac biopsy tissue but also in both sets of biopsies 
from the study group subjects.  Based on this finding, 
changes in nuclear shape appear to act as evidence of 
the development of a coeliac lesion.  
Tubulin is the major component of the microtubules 
and with other cytoskeletal proteins forms the essential 
structural framework of cells [12-36]. In this study, 
enterocyte tubulin fibre parameters were analyzed, 
including tubulin fibre angles, fibre staining intensity 
and fibre density.  Alteration of all these parameters 
was found in the untreated coeliac patients and similar 
significant alterations were observed in the initial and 
repeat biopsies in the study group subjects.  Interestingly, 
significant changes were not observed in the treated 
coeliac patient biopsies. 
Figure 4. Algorithmic created images representing enterocyte nu-
clei (red) in small intestinal mucosa in the normal control 
group (non-coeliac) (A), Untreated coeliac disease (B) 
and in the study group subjects (first biopsy) (C).
 
264
B.M. Mohamed et al.
The re-arrangement of intracellular tubulin may be 
responsible for the alteration in enterocyte morphology 
in the coeliac and study group subjects. This may 
explain why these cells lose their columnar shape. It is 
also possible that these changes may affect the cell:cell 
adherence of intestinal epithelial cells, a well described 
finding in coeliac disease [37-40]. The continuity of the 
surface epithelium is maintained by tight junctions (zona 
occulens) and by actin-rich connections (zona adherens 
and zona maculens), which join the uppermost portions 
of the cells. Tubulin is required for maintaining tight 
junction adherence and this may occur via regulation of 
F-actin [41]. Of interest, actin is a target of IgA auto-
antibodies in coeliac disease and the level of these 
antibodies was found to correlate with the extent of 
intestinal damage [42-43]. It has also been reported that 
IgA anti-actin antibodies could possibly be used to detect 
coeliac patients when they present with only patchy 
intestinal lesions [44]. Recent studies in our laboratory 
have revealed that smooth muscle alpha-actin may be 
the principal antigenic target of these antibodies (J. 
Dunne, personal communication).  
Taken together, the results presented here suggest 
that high content analysis is able to accurately detect 
subtle morphological alterations in enterocytes, even 
in patients with apparently normal histology on routine 
microscopic examination. Thus, these changes may 
be very early features of gut inflammation and it was 
noteworthy that they were observed in the first duodenal 
biopsy of the study group subjects.  It was also of interest 
that the alterations were not more pronounced after 
a clear cut histological lesion had developed. These 
findings are of value in understanding the pathogenesis 
of coeliac disease and may point to a direct damaging 
effect on enterocytes caused by gluten. It is also 
important to note that enterocytes play a direct role in 
the immune response and have been shown to produce 
cytokines such as IL-6, IL-8 and IL-15 in response to 
injury or infection, thereby affecting the function of other 
immunocompetent cells [45].
In summary, this study demonstrates the value 
of digitalized high content analysis of tissue sections 
in coeliac disease. This novel technology could be 
employed to identify patients with early onset gluten 
sensitive enteropathy and could also help dissect 
pathogenic events in coeliac disease at the sub-cellular 
level.  
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